EuroAsia RND — Research & DevelopmentRNDResearch & Development Enquiry 0

Alisertib

Aurora Kinase A (AURKA) Inhibitor

CAS
1028486-01-2
Formula
C27H20ClFN4O4
Mol. weight
518.93 g/mol
Purity
≥99%

Price on request. CoA, HPLC, NMR and SDS available on request. For Research Use Only. Not for human or veterinary use.

2D structure of Alisertib
Structure from PubChem CID 24771867

Alisertib is a selective Aurora Kinase A inhibitor that disrupts mitotic spindle assembly by preventing AURKA-mediated phosphorylation of TACC3 and other centrosomal substrates, leading to multipolar spindle formation and mitotic exit failure. Shows particular activity in MYC-amplified haematological malignancies and MYCN-amplified neuroblastoma and SCLC.

Target class: Aurora, PLK1 and kinesin inhibitors
Research areas: Breast Cancer, Leukemia, Lung Cancer

Related compounds

SMILESCOC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC
InChIKeyZLHFILGSQDJULK-UHFFFAOYSA-N